Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1793, Issue 7, 2009, Pages 1128-1143

  Chen, Jin Qiang ^a   Brown, Terry R ^b   Russo, Jose ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adenosine nucleotide translocase (ANT); Endocrine disrupting chemicals; Estrogen receptor alpha and beta; Estrogens; Glucose transport; Glycolysis; Mitochondrial respiratory chain; Obesity; Tricarboxylic acid cycle

Indexed keywords

4 NONYLPHENOL; 4 OCTYLPHENOL; 4 PROPYLPHENOL; 4,4' ISOPROPYLIDENEDIPHENOL; ADENINE NUCLEOTIDE TRANSLOCASE; ADIPONECTIN; CELL NUCLEUS DNA; CITRATE SYNTHASE; DIETHYLSTILBESTROL; ENDOCRINE DISRUPTOR; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FRUCTOSE 2,6 BISPHOSPHATASE; FRUCTOSE 2,6 BISPHOSPHATASE 4; GESTAGEN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUCOSE TRANSPORTER; MITOCHONDRIAL DNA; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHENOL DERIVATIVE; PHOSPHATIDYLINOSITOL 3 KINASE; PHTHALIC ACID BENZYL BUTYL ESTER; PHYTOESTROGEN; PITAVASTATIN; TAMOXIFEN; TRICARBOXYLIC ACID; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADIPOGENESIS; BODY WEIGHT; CITRIC ACID CYCLE; DISEASE ASSOCIATION; ENERGY METABOLISM; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; FATTY LIVER; GENE EXPRESSION REGULATION; GENE MUTATION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOLYSIS; HEREDITY; HOMEOSTASIS; HORMONE ACTION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC REGULATION; MITOCHONDRION; MOMORDICA CHARANTIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RESPIRATORY CHAIN; REVIEW; SKELETAL MUSCLE; TRANSCRIPTION REGULATION;

ANIMALS; ENDOCRINE DISRUPTORS; ENERGY METABOLISM; ENVIRONMENTAL EXPOSURE; ESTROGENS; HUMANS; OBESITY; SIGNAL TRANSDUCTION;

EID: 67649398814     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2009.03.009     Document Type: Review

References (192)

1. Calle E.E., and Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer. 4 (2004) 579-591
2. Calle E.E., and Thun M.J. Obesity and cancer. Oncogene 23 (2004) 6365-6378
3. Heindel J.J. Endocrine disruptors and the obesity epidemic. Toxicol. Sci. 76 (2003) 247-249
4. Wasan K.M., and Looije N.A. Emerging pharmacological approaches to the treatment of obesity. J. Pharm. Pharm. Sci. 8 (2005) 259-271
5. Menifield C.E., Doty N., and Fletcher A. Obesity in America. ABNF. J. 19 (2008) 83-88
6. Zaninotto P., Head J., Stamatakis E., Wardle H., and Mindell J. Trends in obesity among adults in England from 1993 to 2004 by age and social class and projections of prevalence to 2012. J. Epidemiol. Community Health 63 (2009) 140-146
7. Gu D., Reynolds K., Wu X., Chen J., Duan X., Reynolds R.F., Whelton P.K., and He J. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 365 (2005) 1398-1405
8. Marwaha R.K., Tandon N., Singh Y., Aggarwal R., Grewal K., and Mani K. A study of growth parameters and prevalence of overweight and obesity in school children from Delhi. Indian. Pediatr. 43 (2006) 943-952
9. Chlebowski R.T. Obesity and early-stage breast cancer. J. Clin. Oncol. 23 (2005) 1345-1347
10. Lorincz A.M., and Sukumar S. Molecular links between obesity and breast cancer. Endocr. Relat. Cancer 13 (2006) 279-292
11. Strom S.S., Wang X., Pettaway C.A., Logothetis C.J., Yamamura Y., Do K.A., Babaian R.J., and Troncoso P. Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy. Clin. Cancer Res. 11 (2005) 6889-6894
12. Damcott C.M., Sack P., and Shuldiner A.R. The genetics of obesity. Endocrinol. Metab. Clin. North. Am. 32 (2003) 761-786
13. Brantley P.J., Myers H., and Roy H.J. Environmental and lifestyle influences on obesity. J. La. State. Med. Soc. 157 Spec No 1 (2005) S19-S27
14. Heindel J.J. Role of exposure to environmental chemicals in the developmental basis of disease and dysfunction. Reprod. Toxicol. 23 (2007) 257-259
15. Wade G.N., and Powers J.B. Tamoxifen antagonizes the effects of estradiol on energy balance and estrous behavior in Syrian hamsters. Am. J. Physiol. 265 (1993) R559-562
16. Misso M.L., Murata Y., Boon W.C., Jones M.E., Britt K.L., and Simpson E.R. Cellular and molecular characterization of the adipose phenotype of the aromatase-deficient mouse. Endocrinology 144 (2003) 1474-1480
17. Misso M.L., Hewitt K.N., Boon W.C., Murata Y., Jones M.E., and Simpson E.R. Cholesterol feeding prevents adiposity in the obese female aromatase knockout (ArKO) mouse. Horm. Metab. Res. 37 (2005) 26-31
18. Takeda K., Toda K., Saibara T., Nakagawa M., Saika K., Onishi T., Sugiura T., and Shizuta Y. Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. J. Endocrinol. 176 (2003) 237-246
19. Gao Q., Mezei G., Nie Y., Rao Y., Choi C.S., Bechmann I., Leranth C., Toran-Allerand D., Priest C.A., Roberts J.L., Gao X.B., Mobbs C., Shulman G.I., Diano S., and Horvath T.L. Anorectic estrogen mimics leptin's effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals. Nat. Med. 13 (2007) 89-94
20. Feigelson H.S., Jonas C.R., Teras L.R., Thun M.J., and Calle E.E. Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol. Biomarkers. Prev. 13 (2004) 220-224
21. Demir B., Ozturkoglu E., Solaroglu A., Baskan B., Kandemir O., Karabulut E., and Haberal A. The effects of estrogen therapy and estrogen combined with different androgenic progestins on carbohydrate and lipid metabolism in overweight-obese younger postmenopausal women. Gynecol. Endocrinol. 24 (2008) 347-353
22. Kristensen K., Pedersen S.B., Vestergaard P., Mosekilde L., and Richelsen B. Hormone replacement therapy affects body composition and leptin differently in obese and non-obese postmenopausal women. J. Endocrinol. 163 (1999) 55-62
23. Beato M., Chavez S., and Truss M. Transcriptional regulation by steroid hormones. Steroids 61 (1996) 240-251
24. Beato M., and Sanchez-Pacheco A. Interaction of steroid hormone receptors with the transcription initiation complex. Endocr. Rev. 17 (1996) 587-609
25. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science 240 (1988) 889-895
26. Pettersson K., and Gustafsson J.A. Role of estrogen receptor beta in estrogen action. Annu. Rev. Physiol. 63 (2001) 165-192
27. Tsai M.J., and O'Malley B.W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63 (1994) 451-486
28. Levin E.R. Integration of the extranuclear and nuclear actions of estrogen. Mol. Endocrinol. 19 (2005) 1951-1959
29. Levin E.R. Rapid signaling by steroid receptors. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295 (2008) R1425-1430
30. Levin E.R., and Pietras R.J. Estrogen receptors outside the nucleus in breast cancer. Breast. Cancer Res. Treat. 108 (2008) 351-361
31. Song R.X., Fan P., Yue W., Chen Y., and Santen R.J. Role of receptor complexes in the extranuclear actions of estrogen receptor alpha in breast cancer. Endocr. Relat. Cancer 13 Suppl. 1 (2006) S3-S13
32. Zhang Z., Maier B., Santen R.J., and Song R.X. Membrane association of estrogen receptor alpha mediates estrogen effect on MAPK activation. Biochem. Biophys. Res. Commun. 294 (2002) 926-933
33. Chen J.Q., Brown T.R., and Yager J.D. Mechanisms of hormone carcinogenesis: evolution of views, role of mitochondria. Adv. Exp. Med. Biol. 630 (2008) 1-18
34. Chen J.Q., Yager J.D., and Russo J. Regulation of mitochondrial respiratory chain structure and function by estrogens/estrogen receptors and potential physiological/pathophysiological implications. Biochim. Biophys. Acta 1746 (2005) 1-17
35. Wade G.N., Blaustein J.D., Gray J.M., and Meredith J.M. ICI 182,780: a pure antiestrogen that affects behaviors and energy balance in rats without acting in the brain. Am. J. Physiol. 265 (1993) R1392-1398
36. Jones M.E., Thorburn A.W., Britt K.L., Hewitt K.N., Wreford N.G., Proietto J., Oz O.K., Leury B.J., Robertson K.M., Yao S., and Simpson E.R. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 12735-12740
37. Jones M.E., Thorburn A.W., Britt K.L., Hewitt K.N., Misso M.L., Wreford N.G., Proietto J., Oz O.K., Leury B.J., Robertson K.M., Yao S., and Simpson E.R. Aromatase-deficient (ArKO) mice accumulate excess adipose tissue. J. Steroid. Biochem. Mol. Biol. 79 (2001) 3-9
38. Ohlsson C., Hellberg N., Parini P., Vidal O., Bohlooly Y.M., Rudling M., Lindberg M.K., Warner M., Angelin B., and Gustafsson J.A. Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochem. Biophys. Res. Commun. 278 (2000) 640-645
39. Heine P.A., Taylor J.A., Iwamoto G.A., Lubahn D.B., and Cooke P.S. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 12729-12734
40. Cooke P.S., Heine P.A., Taylor J.A., and Lubahn D.B. The role of estrogen and estrogen receptor-alpha in male adipose tissue. Mol. Cell. Endocrinol. 178 (2001) 147-154
41. Naaz A., Zakroczymski M., Heine P., Taylor J., Saunders P., Lubahn D., and Cooke P.S. Effect of ovariectomy on adipose tissue of mice in the absence of estrogen receptor alpha (ERalpha): a potential role for estrogen receptor beta (ERbeta). Horm. Metab. Res. 34 (2002) 758-763
42. Foryst-Ludwig A., Clemenz M., Hohmann S., Hartge M., Sprang C., Frost N., Krikov M., Bhanot S., Barros R., Morani A., Gustafsson J.A., Unger T., and Kintscher U. Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma. PLoS. Genet. 4 (2008) e1000108
43. Rosenkranz K., Hinney A., Ziegler A., Hermann H., Fichter M., Mayer H., Siegfried W., Young J.K., Remschmidt H., and Hebebrand J. Systematic mutation screening of the estrogen receptor beta gene in probands of different weight extremes: identification of several genetic variants. J. Clin. Endocrinol. Metab. 83 (1998) 4524-4527
44. Nilsson M., Naessen S., Dahlman I., Linden Hirschberg A., Gustafsson J.A., and Dahlman-Wright K. Association of estrogen receptor beta gene polymorphisms with bulimic disease in women. Mol. Psychiatry. 9 (2004) 28-34
45. Liang Y.Q., Akishita M., Kim S., Ako J., Hashimoto M., Iijima K., Ohike Y., Watanabe T., Sudoh N., Toba K., Yoshizumi M., and Ouchi Y. Estrogen receptor beta is involved in the anorectic action of estrogen. Int. J. Obes. Relat. Metab. Disord. 26 (2002) 1103-1109
46. Pallottini V., Bulzomi P., Galluzzo P., Martini C., and Marino M. Estrogen regulation of adipose tissue functions: involvement of estrogen receptor isoforms. Infect. Disord. Drug. Targets. 8 (2008) 52-60
47. Pedram A., Razandi M., Kim J.K., O'Mahony F., Lee E.Y., Luderer U., and Levin E.R. Developmental phenotype of a membrane only estrogen receptor alpha (MOER) mouse. J. Biol. Chem. 284 (2009) 3488-3495
48. Wu C., Kang J.E., Peng L.J., Li H., Khan S.A., Hillard C.J., Okar D.A., and Lange A.J. Enhancing hepatic glycolysis reduces obesity: differential effects on lipogenesis depend on site of glycolytic modulation. Cell. Metab. 2 (2005) 131-140
49. Bhatia A.J., and Wade G.N. Energy balance in pregnant hamsters: a role for voluntary exercise?. Am. J. Physiol. 265 (1993) R563-567
50. Birnbaum L.S., and Fenton S.E. Cancer and developmental exposure to endocrine disruptors. Environ. Health. Perspect. 111 (2003) 389-394
51. Mead M.N. Origins of obesity. Environ. Health. Perspect. 112 (2004) A344
52. Clevenger W.R., Cornwall G.A., Carter M.W., and Bradshaw W.S. Diethylstilbestrol-induced perinatal lethality in the rat. I. Relationship to reduced maternal weight gain. Biol. Reprod. 44 (1991) 575-582
53. Zimmerman S.A., Clevenger W.R., Brimhall B.B., and Bradshaw W.S. Diethylstilbestrol-induced perinatal lethality in the rat. II. Perturbation of parturition. Biol. Reprod. 44 (1991) 583-589
54. Harp J.B., Henry S.A., and DiGirolamo M. Dietary weight loss decreases serum angiotensin-converting enzyme activity in obese adults. Obes. Res. 10 (2002) 985-990
55. Naaz A., Yellayi S., Zakroczymski M.A., Bunick D., Doerge D.R., Lubahn D.B., Helferich W.G., and Cooke P.S. The soy isoflavone genistein decreases adipose deposition in mice. Endocrinology 144 (2003) 3315-3320
56. Ema M., and Miyawaki E. Effects on development of the reproductive system in male offspring of rats given butyl benzyl phthalate during late pregnancy. Reprod. Toxicol. 16 (2002) 71-76
57. Rubin B.S., Murray M.K., Damassa D.A., King J.C., and Soto A.M. Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ. Health. Perspect. 109 (2001) 675-680
58. Kim J.C., Shin H.C., Cha S.W., Koh W.S., Chung M.K., and Han S.S. Evaluation of developmental toxicity in rats exposed to the environmental estrogen bisphenol A during pregnancy. Life. Sci. 69 (2001) 2611-2625
59. Morrissey R.E., George J.D., Price C.J., Tyl R.W., Marr M.C., and Kimmel C.A. The developmental toxicity of bisphenol A in rats and mice. Fundam. Appl. Toxicol. 8 (1987) 571-582
60. Scheepers A., Joost H.G., and Schurmann A. The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function. JPEN. J. Parenter. Enteral. Nutr. 28 (2004) 364-371
61. Neeman M., and Degani H. Early estrogen-induced metabolic changes and their inhibition by actinomycin D and cycloheximide in human breast cancer cells: 31P and 13C NMR studies. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 5585-5589
62. Neeman M., and Degani H. Metabolic studies of estrogen- and tamoxifen-treated human breast cancer cells by nuclear magnetic resonance spectroscopy. Cancer Res. 49 (1989) 589-594
63. Furman E., Rushkin E., Margalit R., Bendel P., and Degani H. Tamoxifen induced changes in MCF7 human breast cancer: in vitro and in vivo studies using nuclear magnetic resonance spectroscopy and imaging. J. Steroid. Biochem. Mol. Biol. 43 (1992) 189-195
64. Rivenzon-Segal D., Rushkin E., Polak-Charcon S., and Degani H. Glucose transporters and transport kinetics in retinoic acid-differentiated T47D human breast cancer cells. Am. J. Physiol. Endocrinol. Metab. 279 (2000) E508-519
65. Rivenzon-Segal D., Boldin-Adamsky S., Seger D., Seger R., and Degani H. Glycolysis and glucose transporter 1 as markers of response to hormonal therapy in breast cancer. Int. J. Cancer. 107 (2003) 177-182
66. Zamora-Leon S.P., Golde D.W., Concha I.I., Rivas C.I., Delgado-Lopez F., Baselga J., Nualart F., and Vera J.C. Expression of the fructose transporter GLUT5 in human breast cancer. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 1847-1852
67. Smith D.E., and Gorski J. Extrogen control of uterine glucose metabolism. An analysis based on the transport and phosphorylation of 2-deoxyglucose. J. Biol. Chem. 243 (1968) 4169-4174
68. Shinkarenko L., Kaye A.M., and Degani H. 13C NMR kinetic studies of the rapid stimulation of glucose metabolism by estrogen in immature rat uterus. NMR. Biomed. 7 (1994) 209-217
69. Kumagai S., Holmang A., and Bjorntorp P. The effects of oestrogen and progesterone on insulin sensitivity in female rats. Acta. Physiol. Scand. 149 (1993) 91-97
70. Cheng C.M., Cohen M., Wang J., and Bondy C.A. Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex. FASEB. J. 15 (2001) 907-915
71. Welch R.D., and Gorski J. Regulation of glucose transporters by estradiol in the immature rat uterus. Endocrinology 140 (1999) 3602-3608
72. Macheda M.L., Rogers S., and Best J.D. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J. Cell. Physiol. 202 (2005) 654-662
73. Im S.S., Kim J.W., Kim T.H., Song X.L., Kim S.Y., Kim H.I., and Ahn Y.H. Identification and characterization of peroxisome proliferator response element in the mouse GLUT2 promoter. Exp. Mol. Med. 37 (2005) 101-110
74. Im S.S., Kang S.Y., Kim S.Y., Kim H.I., Kim J.W., Kim K.S., and Ahn Y.H. Glucose-stimulated upregulation of GLUT2 gene is mediated by sterol response element-binding protein-1c in the hepatocytes. Diabetes 54 (2005) 1684-1691
75. Houston K.D., Copland J.A., Broaddus R.R., Gottardis M.M., Fischer S.M., and Walker C.L. Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferator-activated receptor gamma ligands in uterine leiomyoma. Cancer Res. 63 (2003) 1221-1227
76. Wang X., and Kilgore M.W. Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells. Mol. Cell. Endocrinol. 194 (2002) 123-133
77. Sakurai K., Kawazuma M., Adachi T., Harigaya T., Saito Y., Hashimoto N., Mori C., and Bisphenol A. affects glucose transport in mouse 3T3-F442A adipocytes. Br. J. Pharmacol. 141 (2004) 209-214
78. Bogacka I., Roane D.S., Xi X., Zhou J., Li B., Ryan D.H., and Martin R.J. Expression levels of genes likely involved in glucose-sensing in the obese Zucker rat brain. Nutr. Neurosci. 7 (2004) 67-74
79. Brennan C.L., Hoenig M., and Ferguson D.C. GLUT4 but not GLUT1 expression decreases early in the development of feline obesity. Domest. Anim. Endocrinol. 26 (2004) 291-301
80. Minchenko O.H., Ochiai A., Opentanova L., Ogura T., Minchenko D.O., Caro J., Komisarenko S.V., and Esumi H. Overexpression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4 in the human breast and colon malignant tumors. Biochimie 87 (2005) 1005-1010
81. Kostanyan A., and Nazaryan K. Rat brain glycolysis regulation by estradiol-17 beta. Biochim. Biophys. Acta 1133 (1992) 301-306
82. Reiss N.A. Ontogeny and estrogen responsiveness of creatine kinase and glycolytic enzymes in brain and uterus of rat. Neurosci. Lett. 84 (1988) 197-202
83. Pastorelli R., Carpi D., Airoldi L., Chiabrando C., Bagnati R., Fanelli R., Moverare S., and Ohlsson C. Proteome analysis for the identification of in vivo estrogen-regulated proteins in bone. Proteomics 5 (2005) 4936-4945
84. Yan L., Ge H., Li H., Lieber S.C., Natividad F., Resuello R.R., Kim S.J., Akeju S., Sun A., Loo K., Peppas A.P., Rossi F., Lewandowski E.D., Thomas A.P., Vatner S.F., and Vatner D.E. Gender-specific proteomic alterations in glycolytic and mitochondrial pathways in aging monkey hearts. J. Mol. Cell. Cardiol. 37 (2004) 921-929
85. Vijayalakshmi R., Bamji M.S., and Ramalakshmi B.A. Reduced anaerobic glycolysis in oral contraceptive users. Contraception 38 (1988) 91-97
86. Kelley D.E., Mokan M., and Mandarino L.J. Intracellular defects in glucose metabolism in obese patients with NIDDM. Diabetes 41 (1992) 698-706
87. Choi M.S., Jung U.J., Yeo J., Kim M.J., and Lee M.K. Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice. Diabetes Metab. Res. Rev. 24 (2008) 74-81
88. Ae Park S., Choi M.S., Cho S.Y., Seo J.S., Jung U.J., Kim M.J., Sung M.K., Park Y.B., and Lee M.K. Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice. Life. Sci. 79 (2006) 1207-1213
89. Simoneau J.A., and Kelley D.E. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J. Appl. Physiol. 83 (1997) 166-171
90. Beckett T., Tchernof A., and Toth M.J. Effect of ovariectomy and estradiol replacement on skeletal muscle enzyme activity in female rats. Metabolism 51 (2002) 1397-1401
91. Stirone C., Duckles S.P., Krause D.N., and Procaccio V. Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels. Mol. Pharmacol. 68 (2005) 959-965
92. Yadav R.N. Isocitrate dehydrogenase activity and its regulation by estradiol in tissues of rats of various ages. Cell. Biochem. Funct. 6 (1988) 197-202
93. Gupta G., Srivastava A., and Setty B.S. Androgen-estrogen synergy in the regulation of energy metabolism in epididymis and vas deferens of rhesus monkey. Endocr. Res. 17 (1991) 383-394
94. Nilsen J., Irwin R.W., Gallaher T.K., and Brinton R.D. Estradiol in vivo regulation of brain mitochondrial proteome. J. Neurosci. 27 (2007) 14069-14077
95. Baltrus B.M., and Melchior J.B. Effects of administration of estrogens upon enzymes of rat pituitary. II. Aconitase, succinoxidase, and transaminase. Cancer Res. 21 (1961) 1360-1364
96. Raben A., Mygind E., and Astrup A. Lower activity of oxidative key enzymes and smaller fiber areas in skeletal muscle of postobese women. Am. J. Physiol. 275 (1998) E487-494
97. Goffart S., and Wiesner R.J. Regulation and co-ordination of nuclear gene expression during mitochondrial biogenesis. Exp. Physiol. 88 (2003) 33-40
98. Green D.R., and Reed J.C. Mitochondria and apoptosis. Science 281 (1998) 1309-1312
99. Bossy-Wetzel E., and Green D.R. Apoptosis: checkpoint at the mitochondrial frontier. Mutat. Res. 434 (1999) 243-251
100. Grivell L.A. Nucleo-mitochondrial interactions in mitochondrial gene expression. Crit. Rev. Biochem. Mol. Biol. 30 (1995) 121-164
101. Garesse R., and Vallejo C.G. Animal mitochondrial biogenesis and function: a regulatory cross-talk between two genomes. Gene 263 (2001) 1-16
102. Chen J.Q., Yager J.D., and Russo J. Regulation of mitochondrial respiratory chain structure and function by estrogens/estrogen receptors and potential physiological/pathophysiological implications. Biochim. Biophys. Acta 46 1 (2005) 1-17
103. Vic P., Vignon F., Derocq D., and Rochefort H. Effect of estradiol on the ultrastructure of the MCF7 human breast cancer cells in culture. Cancer Res. 42 (1982) 667-673
104. Alkhalaf M., Chaminadas G., Propper A.Y., and Adessi G.L. Ultrastructural changes induced by oestradiol-17 beta, progesterone and oestrone-3-sulphate in guinea-pig endometrial glandular cells grown in primary culture. J. Endocrinol. 122 (1989) 439-444
105. Tam C.C., and Wong Y.C. Ultrastructural study of the effects of 17 beta-oestradiol on the lateral prostate and seminal vesicle of the castrated guinea pig. Acta Anat. (Basel). 141 (1991) 51-62
106. Tam C.C., Wong Y.C., White F.H., and Fowler J.P. Morphometric and stereological analysis of the effects of 17 beta-estradiol on the glandular epithelium of the castrated guinea pig lateral prostate. Prostate 19 (1991) 279-297
107. Roberts C.M. Szego, The influence of steroids on uterine respiration and glycolysis. J. Biol. Chem. 201 (1953) 21-30
108. Bayliss D.A., Cidlowski J.A., and Millhorn D.E. The stimulation of respiration by progesterone in ovariectomized cat is mediated by an estrogen-dependent hypothalamic mechanism requiring gene expression. Endocrinology 126 (1990) 519-527
109. Sergeev P.V., Khalilov E.M., Obraztsov N.V., and Seifulla R.D. [Effect of steroid hormones on the rate of NADPH and NADH oxidation by rat liver microsomes]. Farmakol. Toksikol. 38 (1975) 600-603
110. Sergeev P.V., Seifulla R.D., Maiskii A.I., Denisov Iu P., and Nikitina Z.K. Effect of estrogens on the parameters of oxidative phosphorylation in the liver mitochondria and uterus. Akush. Ginekol. (Mosk). (1975) 63
111. Sergeev P.V., Seifulla R.D., Maiskii A.I., Denisov Iu P., and Nikitina Z.K. Effect of estrogens on the indicators of oxidative phosphorylation in the mitochondria of the liver and uterine cells. Akush. Ginekol. (Mosk). (1975) 60-61
112. Salmony D. The effect of oestrogens and chemically related compounds on the respiration of yeast and on oxidative phosphorylation. Biochem. J. 62 (1956) 411-416
113. Takenaka S. Studies on the effect of sex-hormones on oxidative phosphorylation. J. Jpn. Obstet. Gynecol. Soc. 12 (1965) 89-93
114. Zhai P., Eurell T.E., Cotthaus R., Jeffery E.H., Bahr J.M., and Gross D.R. Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats. Am. J. Physiol. Heart Circ. Physiol. 279 (2000) H2766-2775
115. Zhai P., Eurell T.E., Cooke P.S., Lubahn D.B., and Gross D.R. Myocardial ischemia-reperfusion injury in estrogen receptor-alpha knockout and wild-type mice. Am. J. Physiol. Heart Circ. Physiol. 278 (2000) H1640-1647
116. Zhai P., Eurell T.E., Cotthaus R.P., Jeffery E.H., Bahr J.M., and Gross D.R. Effects of dietary phytoestrogen on global myocardial ischemia-reperfusion injury in isolated female rat hearts. Am. J. Physiol. Heart Circ. Physiol. 281 (2001) H1223-1232
117. Toda K., Takeda K., Okada T., Akira S., Saibara T., Kaname T., Yamamura K., Onishi S., and Shizuta Y. Targeted disruption of the aromatase P450 gene (Cyp19) in mice and their ovarian and uterine responses to 17beta-oestradiol. J. Endocrinol. 170 (2001) 99-111
118. Justo R., Frontera M., Pujol E., Rodriguez-Cuenca S., Llado I., Garcia-Palmer F.J., Roca P., and Gianotti M. Gender-related differences in morphology and thermogenic capacity of brown adipose tissue mitochondrial subpopulations. Life. Sci. 76 (2005) 1147-1158
119. Justo R., Boada J., Frontera M., Oliver J., Bermudez J., and Gianotti M. Gender dimorphism in rat liver mitochondrial oxidative metabolism and biogenesis. Am. J. Physiol. Cell Physiol. 289 (2005) C372-378
120. Rodriguez-Cuenca S., Pujol E., Justo R., Frontera M., Oliver J., Gianotti M., and Roca P. Sex-dependent thermogenesis, differences in mitochondrial morphology and function, and adrenergic response in brown adipose tissue. J. Biol. Chem. 277 (2002) 42958-42963
121. Valle A., Catala-Niell A., Colom B., Garcia-Palmer F.J., Oliver J., and Roca P. Sex-related differences in energy balance in response to caloric restriction. Am. J. Physiol. Endocrinol. Metab. 289 (2005) E15-22
122. Zhu Y., Bian Z., Lu P., Karas R.H., Bao L., Cox D., Hodgin J., Shaul P.W., Thoren P., Smithies O., Gustafsson J.A., and Mendelsohn M.E. Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 295 (2002) 505-508
123. Watson Jr. B., Khan M.A., Desmond R.A., and Bergman S. Mitochondrial DNA mutations in black Americans with hypertension-associated end-stage renal disease. Am. J. Kidney Dis. 38 (2001) 529-536
124. Head G.A., Obeyesekere V.R., Jones M.E., Simpson E.R., and Krozowski Z.S. Aromatase-deficient (ArKO) mice have reduced blood pressure and baroreflex sensitivity. Endocrinology 145 (2004) 4286-4291
125. Monje P., and Boland R. Subcellular distribution of native estrogen receptor alpha and beta isoforms in rabbit uterus and ovary. J. Cell. Biochem. 82 (2001) 467-479
126. Yang S.H., Liu R., Perez E.J., Wen Y., Stevens Jr. S.M., Valencia T., Brun-Zinkernagel A.M., Prokai L., Will Y., Dykens J., Koulen P., and Simpkins J.W. Mitochondrial localization of estrogen receptor beta. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 4130-4135
127. Milner T.A., Ayoola K., Drake C.T., Herrick S.P., Tabori N.E., McEwen B.S., Warrier S., and Alves S.E. Ultrastructural localization of estrogen receptor beta immunoreactivity in the rat hippocampal formation. J. Comp. Neurol. 491 (2005) 81-95
128. Chen J.Q., Delannoy M., Cooke C., and Yager J.D. Mitochondrial localization of ERalpha and ERbeta in human MCF7 cells. Am. J. Physiol. Endocrinol. Metab. 286 (2004) E1011-1022
129. Chen J.Q., Eshete M., Alworth W.L., and Yager J.D. Binding of MCF-7 cell mitochondrial proteins and recombinant human estrogen receptors alpha and beta to human mitochondrial DNA estrogen response elements. J. Cell. Biochem. 93 (2004) 358
130. Pedram A., Razandi M., Wallace D.C., and Levin E.R. Functional Estrogen Receptors in the Mitochondria of Breast Cancer Cells. Mol. Biol. Cell. 17 (2006) 2125-2137
131. Cammarata P.R., Chu S., Moor A., Wang Z., Yang S.H., and Simpkins J.W. Subcellular distribution of native estrogen receptor alpha and beta subtypes in cultured human lens epithelial cells. Exp. Eye. Res. 78 (2004) 861-871
132. Cammarata P.R., Flynn J., Gottipati S., Chu S., Dimitrijevich S., Younes M., Skliris G., and Murphy L.C. Differential expression and comparative subcellular localization of estrogen receptor beta isoforms in virally transformed and normal cultured human lens epithelial cells. Exp. Eye. Res. 81 (2005) 165-175
133. Solakidi S., Psarra A.M., and Sekeris C.E. Differential subcellular distribution of estrogen receptor isoforms: localization of ERalpha in the nucleoli and ERbeta in the mitochondria of human osteosarcoma SaOS-2 and hepatocarcinoma HepG2 cell lines. Biochim. Biophys. Acta 1745 (2005) 382-392
134. Solakidi S., Psarra A.M., Nikolaropoulos S., and Sekeris C.E. Estrogen receptors {alpha} and {beta} (ER{alpha} and ER{beta}) and androgen receptor (AR) in human sperm: localization of ER{beta} and AR in mitochondria of the midpiece. Hum. Reprod. 20 (2005) 3481-3487
135. Chen J.Q., Eshete M., Alworth W.L., and Yager J.D. Binding of MCF-7 cell mitochondrial proteins and recombinant human estrogen receptors alpha and beta to human mitochondrial DNA estrogen response elements. J. Cell. Biochem. 93 (2004) 358-373
136. Stirone C., Duckles S.P., Krause D.N., and Procaccio V. Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels. Mol. Pharmacol. 67 (2005) 959-965
137. Van Itallie C.M., and Dannies P.S. Estrogen induces accumulation of the mitochondrial ribonucleic acid for subunit II of cytochrome oxidase in pituitary tumor cells. Mol. Endocrinol. 2 (1988) 332-337
138. Bettini E., and Maggi A. Estrogen induction of cytochrome c oxidase subunit III in rat hippocampus. J. Neurochem. 58 (1992) 1923-1929
139. Law S.W., Apostolakis E.M., Samora P.J., O'Malley B.W., and Clark J.H. Hormonal regulation of hypothalamic gene expression: identification of multiple novel estrogen induced genes. J. Steroid. Biochem. Mol. Biol. 51 (1994) 131-136
140. Chen J., Schwartz D.A., Young T.A., Norris J.S., and Yager J.D. Identification of genes whose expression is altered during mitosuppression in livers of ethinyl estradiol-treated female rats. Carcinogenesis 17 (1996) 2783-2786
141. Chen J., Gokhale M., Li Y., Trush M.A., and Yager J.D. Enhanced levels of several mitochondrial mRNA transcripts and mitochondrial superoxide production during ethinyl estradiol-induced hepatocarcinogenesis and after estrogen treatment of HepG2 cells. Carcinogenesis 19 (1998) 2187-2193
142. Chen J., Delannoy M., Odwin S., He P., Trush M.A., and Yager J.D. Enhanced mitochondrial gene transcript, ATP, bcl-2 protein levels, and altered glutathione distribution in ethinyl estradiol-treated cultured female rat hepatocytes. Toxicol. Sci. 75 (2003) 271-278
143. Ye P., Yoshioka M., Gan L., and St-Amand J. Regulation of global gene expression by ovariectomy and estrogen in female adipose tissue. Obes. Res. 13 (2005) 1024-1030
144. Chen J.Q., Russo P.A., Cooke C., Russo I.H., and Russo J. ERbeta shifts from mitochondria to nucleus during estrogen-induced neoplastic transformation of human breast epithelial cells and is involved in estrogen-induced synthesis of mitochondrial respiratory chain proteins. Biochim. Biophys. Acta 1773 (2007) 1732-1746
145. Borras C., Sastre J., Garcia-Sala D., Lloret A., Pallardo F.V., and Vina J. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic. Biol. Med. 34 (2003) 546-552
146. Villablanca A.C., Lewis K.A., Tham D., and Rutledge J.C. Differential regulation of gene expression by ovariectomy in mouse aorta. Physiol. Genomics. 12 (2003) 175-185
147. Sekeris C.E. The mitochondrial genome: a possible primary site of action of steroid hormones. In. Vivo. 4 (1990) 317-320
148. Demonacos C.V., Karayanni N., Hatzoglou E., Tsiriyiotis C., Spandidos D.A., and Sekeris C.E. Mitochondrial genes as sites of primary action of steroid hormones. Steroids 61 (1996) 226-232
149. Roberts S., and Szego C.M. Steroid interaction in the metabolism of reproductive target organs. Physiol. Rev. 33 (1953) 593-629
150. Chau K.Y., Lam H.Y., and Lee K.L. Estrogen treatment induces elevated expression of HMG1 in MCF-7 cells. Exp. Cell. Res. 241 (1998) 269-272
151. Watanabe T., Inoue S., Hiroi H., Orimo A., Kawashima H., and Muramatsu M. Isolation of estrogen-responsive genes with a CpG island library. Mol. Cell. Biol. 18 (1998) 442-449
152. Thompson C.J., Tam N.N., Joyce J.M., Leav I., and Ho S.M. Gene expression profiling of testosterone and estradiol-17 beta-induced prostatic dysplasia in Noble rats and response to the antiestrogen ICI 182,780. Endocrinology 143 (2002) 2093-2105
153. Weisz A., Basile W., Scafoglio C., Altucci L., Bresciani F., Facchiano A., Sismondi P., Cicatiello L., and De Bortoli M. Molecular identification of ERalpha-positive breast cancer cells by the expression profile of an intrinsic set of estrogen regulated genes. J. Cell. Physiol. 200 (2004) 440-450
154. Tikkanen M.K., Carter D.J., Harris A.M., Le H.M., Azorsa D.O., Meltzer P.S., and Murdoch F.E. Endogenously expressed estrogen receptor and coactivator AIB1 interact in MCF-7 human breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 12536-12540
155. Mattingly K.A., Ivanova M.M., Riggs K.A., Wickramasinghe N.S., Barch M.J., and Klinge C.M. Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis. Mol. Endocrinol. 22 (2008) 609-622
156. Stirone C., Boroujerdi A., Duckles S.P., and Krause D.N. Estrogen receptor activation of phosphoinositide-3 kinase, akt, and nitric oxide signaling in cerebral blood vessels: rapid and long-term effects. Mol. Pharmacol. 67 (2005) 105-113
157. Chen J., Li Y., Lavigne J.A., Trush M.A., and Yager J.D. Increased mitochondrial superoxide production in rat liver mitochondria, rat hepatocytes, and HepG2 cells following ethinyl estradiol treatment. Toxicol. Sci. 51 (1999) 224-235
158. Chen J., Gokhale M., Schofield B., Odwin S., and Yager J.D. Inhibition of TGF-beta-induced apoptosis by ethinyl estradiol in cultured, precision cut rat liver slices and hepatocytes. Carcinogenesis 21 (2000) 1205-1211
159. Kamei Y., Suzuki M., Miyazaki H., Tsuboyama-Kasaoka N., Wu J., Ishimi Y., and Ezaki O. Ovariectomy in mice decreases lipid metabolism-related gene expression in adipose tissue and skeletal muscle with increased body fat. J. Nutr. Sci. Vitaminol. (Tokyo). 51 (2005) 110-117
160. Watson J.D., Oster S.K., Shago M., Khosravi F., and Penn L.Z. Identifying genes regulated in a Myc-dependent manner. J. Biol. Chem. 277 (2002) 36921-36930
161. Menssen A., and Hermeking H. Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 6274-6279
162. O'Connell B.C., Cheung A.F., Simkevich C.P., Tam W., Ren X., Mateyak M.K., and Sedivy J.M. A large scale genetic analysis of c-Myc-regulated gene expression patterns. J. Biol. Chem. 278 (2003) 12563-12573
163. Li F., Wang Y., Zeller K.I., Potter J.J., Wonsey D.R., O'Donnell K.A., Kim J.W., Yustein J.T., Lee L.A., and Dang C.V. Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol. Cell. Biol. 25 (2005) 6225-6234
164. Cheng A.S., Jin V.X., Fan M., Smith L.T., Liyanarachchi S., Yan P.S., Leu Y.W., Chan M.W., Plass C., Nephew K.P., Davuluri R.V., and Huang T.H. Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters. Mol. Cell. 21 (2006) 393-404
165. Too C.K., Giles A., and Wilkinson M. Estrogen stimulates expression of adenine nucleotide translocator ANT1 messenger RNA in female rat hearts. Mol. Cell. Endocrinol. 150 (1999) 161-167
166. Belzacq A.S., and Brenner C. The adenine nucleotide translocator: a new potential chemotherapeutic target. Curr. Drug. Targets. 4 (2003) 517-524
167. Belzacq A.S., Vieira H.L., Verrier F., Vandecasteele G., Cohen I., Prevost M.C., Larquet E., Pariselli F., Petit P.X., Kahn A., Rizzuto R., Brenner C., and Kroemer G. Bcl-2 and Bax modulate adenine nucleotide translocase activity. Cancer Res. 63 (2003) 541-546
168. Garcia-Segura L.M., Cardona-Gomez P., Naftolin F., and Chowen J.A. Estradiol upregulates Bcl-2 expression in adult brain neurons. NeuroReport 9 (1998) 593-597
169. Wang T.T., and Phang J.M. Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res. 55 (1995) 2487-2489
170. Safe S. Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions. Vitam. Horm. 62 (2001) 231-252
171. Alkayed N.J., Goto S., Sugo N., Joh H.D., Klaus J., Crain B.J., Bernard O., Traystman R.J., and Hurn P.D. Estrogen and Bcl-2: gene induction and effect of transgene in experimental stroke. J. Neurosci. 21 (2001) 7543-7550
172. Li L., Backer J., Wong A.S., Schwanke E.L., Stewart B.G., and Pasdar M. Bcl-2 expression decreases cadherin-mediated cell-cell adhesion. J. Cell. Sci. 116 (2003) 3687-3700
173. Zhao L., Wu T.W., and Brinton R.D. Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain Res. 1010 (2004) 22-34
174. Murphy E., Imahashi K., and Steenbergen C. Bcl-2 regulation of mitochondrial energetics. Trends Cardiovasc. Med. 15 (2005) 283-290
175. Cardoso C.M., Moreno A.J., Almeida L.M., and Custodio J.B. Comparison of the changes in adenine nucleotides of rat liver mitochondria induced by tamoxifen and 4-hydroxytamoxifen. Toxicol. In Vitro 17 (2003) 663-670
176. Herrero P., Soto P.F., Dence C.S., Kisrieva-Ware Z., Delano D.A., Peterson L.R., and Gropler R.J. Impact of hormone replacement on myocardial fatty acid metabolism: potential role of estrogen. J. Nucl. Cardiol. 12 (2005) 574-581
177. Toda K., Takeda K., Akira S., Saibara T., Okada T., Onishi S., and Shizuta Y. Alternations in hepatic expression of fatty-acid metabolizing enzymes in ArKO mice and their reversal by the treatment with 17beta-estradiol or a peroxisome proliferator. J. Steroid. Biochem. Mol. Biol. 79 (2001) 11-17
178. Nemoto Y., Toda K., Ono M., Fujikawa-Adachi K., Saibara T., Onishi S., Enzan H., Okada T., and Shizuta Y. Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice. J. Clin. Invest. 105 (2000) 1819-1825
179. Egawa T., Toda K., Nemoto Y., Ono M., Akisaw N., Saibara T., Hayashi Y., Hiroi M., Enzan H., and Onishi S. Pitavastatin ameliorates severe hepatic steatosis in aromatase-deficient (Ar-/-) mice. Lipids 38 (2003) 519-523
180. Yun J.W., Shin E.S., Cho S.Y., Kim S.H., Kim C.W., Lee T.R., and Kim B.H. The effects of BADGE and caffeine on the time-course response of adiponectin and lipid oxidative enzymes in high fat diet-fed C57BL/6J mice: correlation with reduced adiposity and steatosis. Exp. Anim. 57 (2008) 461-469
181. Chan L.L., Chen Q., Go A.G., Lam E.K., and Li E.T. Reduced adiposity in bitter melon (Momordica charantia)-fed rats is associated with increased lipid oxidative enzyme activities and uncoupling protein expression. J. Nutr. 135 (2005) 2517-2523
182. Huang H.L., Hong Y.W., Wong Y.H., Chen Y.N., Chyuan J.H., Huang C.J., and Chao P.M. Bitter melon (Momordica charantia L.) inhibits adipocyte hypertrophy and down regulates lipogenic gene expression in adipose tissue of diet-induced obese rats. Br. J. Nutr. 99 (2008) 230-239
183. Chen Q., Chan L.L., and Li E.T. Bitter melon (Momordica charantia) reduces adiposity, lowers serum insulin and normalizes glucose tolerance in rats fed a high fat diet. J. Nutr. 133 (2003) 1088-1093
184. Chen Q., and Li E.T. Reduced adiposity in bitter melon (Momordica charantia) fed rats is associated with lower tissue triglyceride and higher plasma catecholamines. Br. J. Nutr. 93 (2005) 747-754
185. Wolfram S., Wang Y., and Thielecke F. Anti-obesity effects of green tea: from bedside to bench. Mol. Nutr. Food. Res. 50 (2006) 176-187
186. Bose M., Lambert J.D., Ju J., Reuhl K.R., Shapses S.A., and Yang C.S. The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J. Nutr. 138 (2008) 1677-1683
187. Korsrud G.O., and Baldwin R.L. Effects of endocrinectomy and hormone replacement therapies upon enzyme activities in lactating rat mammary glands. Biol. Reprod. 1 (1969) 21-30
188. Eckstein B., and Villee C.A. Effect of estradiol on enzymes of carbohydrate metabolism in rat uterus. Endocrinology 78 (1966) 409-411
189. Eckstein B., and Shalem M. Influence of oestradiol on citrate accumulation in the uterus and blood of fluoroacetate-treated rats. J. Endocrinol. 34 (1966) 227-231
190. Riu E., Ferre T., Hidalgo A., Mas A., Franckhauser S., Otaegui P., and Bosch F. Overexpression of c-myc in the liver prevents obesity and insulin resistance. FASEB J. 17 (2003) 1715-1717
191. Danilovich N., Babu P.S., Xing W., Gerdes M., Krishnamurthy H., and Sairam M.R. Estrogen deficiency, obesity, and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice. Endocrinology 141 (2000) 4295-4308
192. Jones A.P., McElroy J.F., Crnic L., and Wade G.N. Effects of ovariectomy on thermogenesis in brown adipose tissue and liver in Syrian hamsters. Physiol. Behav. 50 (1991) 41-45